DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Gane E, Lawitz E, Pugatch D. , et al.
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment.
N Engl J Med 2017;
377 (15) 1448-1455
We do not assume any responsibility for the contents of the web pages of other providers.